CancerMPact® Emerging Technologies

Learn about the Top 60 most promising
oncology pipeline products

A more critical evaluation of drugs in development

Emerging Technologies evaluates and ranks the key success factors and overall commercial viability of the most promising agents—drugs that will have a significant commercial impact in the next five years—by tumor type, stage, and line of therapy.

• Detailed clinical summary not limited to primary indication
• Identifies products with greatest potential for real near-term impact
• Expert commentary on development and regulatory issues affecting the product
• Estimated launch timelines by year for initial and likely subsequent indications
• Evaluation of potential market opportunities

For more information on MattsonJack's oncology services or knowledgeware products, phone: 650.403.7001 or e-mail us at info@mattsonjack.com.